Log in
Enquire now

List of Domantis Limited patents

List of Domantis Limited patents
List of Siemens Canada patents
List of InControl Medical patents
List of Outokumpu patents
Carbon nanotube venture capital investors
CEOs of identity companies
Patents where
Current Assignee
Name
is
‌
Domantis Limited
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 6846634 Method to screen phage display libraries with different ligands

Patent 6846634 was granted and assigned to Domantis Limited on January, 2005 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
6846634
January 25, 2005
‌
US Patent 7563443 Monovalent anti-CD40L antibody polypeptides and compositions thereof

Patent 7563443 was granted and assigned to Domantis Limited on July, 2009 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
7563443
July 21, 2009
‌
US Patent 7442159 Selection system

Patent 7442159 was granted and assigned to Domantis Limited on October, 2008 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
7442159
October 28, 2008
‌
US Patent 7696320 Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor

Patent 7696320 was granted and assigned to Domantis Limited on April, 2010 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
7696320
April 13, 2010
‌
US Patent 9321832 Ligand

Patent 9321832 was granted and assigned to Domantis Limited on April, 2016 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
9321832
April 26, 2016
‌
US Patent 8921528 Bispecific fusion antibodies with enhanced serum half-life

Patent 8921528 was granted and assigned to Domantis Limited on December, 2014 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8921528
December 30, 2014
‌
US Patent 9629909 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue

Patent 9629909 was granted and assigned to Domantis Limited on April, 2017 by the United States Patent and Trademark Office.

‌
Domantis Limited
‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
9629909
April 25, 2017
‌
US Patent 8129503 Agents that bind a target in pulmonary tissue for targeting respiratory diseases

Patent 8129503 was granted and assigned to Domantis Limited on March, 2012 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8129503
March 6, 2012
‌
US Patent 8680018 Selection system

Patent 8680018 was granted and assigned to Domantis Limited on March, 2014 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8680018
March 25, 2014
‌
US Patent 8398979 Polypeptides, antibody variable domains and antagonists

Patent 8398979 was granted and assigned to Domantis Limited on March, 2013 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8398979
March 19, 2013
‌
US Patent 10072089 Polypeptides, antibody variable domains and antagonists

Patent 10072089 was granted and assigned to Domantis Limited on September, 2018 by the United States Patent and Trademark Office.

‌
Domantis Limited
‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
10072089
September 11, 2018
‌
US Patent 7927596 Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptides

Patent 7927596 was granted and assigned to Domantis Limited on April, 2011 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
7927596
April 19, 2011
‌
US Patent 8084213 Selection

Patent 8084213 was granted and assigned to Domantis Limited on December, 2011 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8084213
December 27, 2011
‌
US Patent 9562090 Polypeptides, antibody variable domains and antagonists

Patent 9562090 was granted and assigned to Domantis Limited on February, 2017 by the United States Patent and Trademark Office.

‌
Domantis Limited
‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
9562090
February 7, 2017
‌
US Patent 8877186 Polypeptides, antibody variable domains and antagonists

Patent 8877186 was granted and assigned to Domantis Limited on November, 2014 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8877186
November 4, 2014
‌
US Patent 7846721 GAS1 universal leader

Patent 7846721 was granted and assigned to Domantis Limited on December, 2010 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
7846721
December 7, 2010
‌
US Patent 7829096 CD40L-specific monovalent polypeptides

Patent 7829096 was granted and assigned to Domantis Limited on November, 2010 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
7829096
November 9, 2010
‌
US Patent 9028822 Antagonists against TNFR1 and methods of use therefor

Patent 9028822 was granted and assigned to Domantis Limited on May, 2015 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
9028822
May 12, 2015
‌
US Patent 8357780 Polypeptides, antibody variable domains and antagonists methods for

Patent 8357780 was granted and assigned to Domantis Limited on January, 2013 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8357780
January 22, 2013
‌
US Patent 8524236 Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals

Patent 8524236 was granted and assigned to Domantis Limited on September, 2013 by the United States Patent and Trademark Office.

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8524236
September 3, 2013
‌
US Patent 8497244 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue

‌
Domantis Limited
United States Patent and Trademark Office
United States Patent and Trademark Office
8497244
July 30, 2013
21 results
0 selected
21 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us